Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors

Lengyel E., Makowski L., DiGiovanni J., Kolonin MG.

Narrative Review on Chronic Inflammation, published in Trends Cancer (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Trends Cancer (2018)
Reported sample size
—
Source database
Europe PMC
PMID
29709261
PMCID
PMC5932630
DOI
10.1016/j.trecan.2018.03.004
Citations
334

Abstract (original English)

Obesity has been linked to the increased risk and aggressiveness of many types of carcinoma. A state of chronic inflammation in adipose tissue (AT), resulting in genotoxic stress, may contribute to carcinogenesis and cancer initiation. Evidence that AT plays a role in cancer aggressiveness is solid and mounting. During cancer progression, tumor cells engage in a metabolic symbiosis with adjacent AT. Mature adipocytes provide adipokines and lipids to cancer cells, while stromal and immune cells from AT infiltrate carcinomas and locally secrete paracrine factors within the tumor microenvironment. This review focuses on the crosstalk between AT and tumor cells that promotes tumor growth and increases cellular lipid metabolism, metastasis, and chemoresistance.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueLeukocytesAdipocytesAnimalsHumansNeoplasmsObesityCell CommunicationDrug Resistance, Neoplasm

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research